The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Josep Gomez-Lara
Showing 1-20 of 22 articles
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Alfonso F,
Cequier A,
Romaní S,
Bordes P,
Serra A,
Iñiguez A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Cuesta J,
Gómez-Hospital JA,
Sabaté M
August 5, 2022 | 10.4244/EIJ-D-21-00651
Target lesion revascularisation of bioresorbable metal scaffolds: a case series study and literature review
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Sanchis J,
Fernández-Díaz J,
Artaiz-Urdaci M,
Alfonso F,
Garcia-Garcia HM,
Sabaté M
January 20, 2021 | 10.4244/EIJ-D-19-00421
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J,
Ortega-Paz L,
Brugaletta S,
Cuesta J,
Romaní S,
Serra A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Antuña P,
Romaguera R,
Regueiro A,
Rivero F,
Cequier A,
Alfonso F,
Gómez-Hospital JA,
Sabaté M
December 4, 2020 | 10.4244/EIJ-D-20-00198
Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial
Gomez-Lara J,
Salvatella N,
Romaguera R,
Brugaletta S,
Nato M,
Roura G,
Ferreiro J,
Teruel L,
Gracida M,
Sabaté M,
Vaquerizo B,
Cequier A,
Gomez-Hospital J
June 12, 2020 | 10.4244/EIJ-D-18-01203
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
Brugaletta S,
Gori T,
Tousek P,
Gomez-Lara J,
Pinar E,
Ortega-Paz L,
Schulz E,
Kocka V,
Münzel T,
Cequier A,
Buono A,
Serruys P,
Sabaté M
March 20, 2020 | 10.4244/EIJ-D-19-00773
Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study)
Gheorghe L,
Millán X,
Jimenez-Kockar M,
Gomez-Lara J,
Arzamendi D,
Danduch L,
Agudelo V,
Serra A
May 20, 2019 | 10.4244/EIJ-D-18-00567
Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up
Paoletti G,
Gomez-Lara J,
Brugaletta S,
Nato M,
Romaguera R,
Roura G,
Ferreiro JL,
Teruel L,
Gracida M,
Ortega-Paz L,
Gomez-Hospital J,
Sabaté M,
Cequier A
June 20, 2018 | 10.4244/EIJ-D-17-00255
Invasive strategy and frailty in very elderly patients with acute coronary syndromes
Llao I,
Ariza-Sole A,
Sanchis J,
Alegre O,
López-Palop R,
Formiga F,
Marin F,
Vidan MT,
Martínez-Sellés M,
Sionis A,
Vives-Borras M,
Gomez-Hospital J,
Gomez-Lara J,
Roura G,
Díez-Villanueva P,
Núñez-Gil I,
Maristany J,
Asmarats L,
Bueno H,
Abu-Assi E,
Cequier A
June 14, 2018 | 10.4244/EIJ-D-18-00099
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G,
Moscarella E,
Brugaletta S,
Pernigotti A,
Ortega-Paz L,
Gomez-Lara J,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Bethencourt A,
Vázquez N,
Valgimigli M,
Serruys P,
Sabaté M
March 20, 2018 | 10.4244/EIJ-D-17-00608
IVUS-guided treatment strategies for definite late and very late stent thrombosis
Gomez-Lara J,
Salvatella N,
Gonzalo N,
Hernandez Hernandez F,
Fernandez-Nofrerias E,
Sanchez Recalde A,
Bastante T,
Marcano A,
Romaguera R,
Ferreiro JL,
Roura G,
Teruel L,
Ariza-Sole A,
Miranda-Guardiola F,
Garcia-Abad V,
Gomez-Hospital J,
Alfonso F,
Cequier A
December 9, 2016 | 10.4244/EIJY15M12_08
Preserved endothelial vasomotor function after everolimus-eluting stent implantation
Roura G,
Homs S,
Ferreiro JL,
Gomez-Lara J,
Romaguera R,
Teruel L,
Sanchez-Elvira G,
Ariza-Sole A,
Gomez-Hospital J,
Cequier A
October 20, 2015 | 10.4244/EIJY14M07_09
Coronary perforation after bioresorbable vascular scaffold implantation
Gomez-Lara J,
Teruel L,
Romaguera R,
Roura G,
Ferreiro JL,
Sanchez-Elvira G,
Gomez-Hospital J,
Cequier A
April 20, 2015 | 10.4244/EIJV10I12A253
Lumen enlargement of the coronary segments located distal to chronic total occlusions successfully treated with drug-eluting stents at follow-up
Gomez-Lara J,
Teruel L,
Homs S,
Ferreiro JL,
Romaguera R,
Roura G,
Sanchez-Elvira G,
Jara F,
Brugaletta S,
Gomez-Hospital J,
Cequier A
February 20, 2014 | 10.4244/EIJV9I10A199
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial
Brugaletta S,
Gomez-Lara J,
Bruining N,
Radu M,
van Geuns R,
Thuesen L,
McClean D,
Koolen J,
Windecker S,
Whitbourn R,
Oberhauser J,
Rapoza R,
Ormiston J,
Garcia-Garcia HM,
Serruys P
July 27, 2012 | 10.4244/EIJV8I3A54
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study
Gomez-Lara J,
Diletti R,
Brugaletta S,
Onuma Y,
Farooq V,
Thuesen L,
McClean D,
Koolen J,
Ormiston J,
Windecker S,
Whitbourn R,
Dudek D,
Dorange C,
Veldhof S,
Rapoza R,
Regar E,
Garcia-Garcia HM,
Serruys P
June 27, 2012
CRosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of success
Garcia-Garcia HM,
Brugaletta S,
van Mieghem C,
Gonzalo N,
Diletti R,
Gomez-Lara J,
Airoldi F,
Carlino M,
Tavano D,
Chieffo A,
Montorfano M,
Michev I,
Colombo A,
van der Ent M,
Serruys P
August 30, 2011 | 10.4244/EIJV7I4A78
Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application
Farooq V,
Onuma Y,
Radu M,
Okamura T,
Gomez-Lara J,
Brugaletta S,
Gogas B,
van Geuns R,
Regar E,
Schultz C,
Windecker S,
Lefèvre T,
Brueren B,
Powers J,
Perkins L,
Rapoza R,
Virmani R,
Garcia-Garcia HM,
Serruys P
July 29, 2011 | 10.4244/EIJV7I3A64
Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study
Garg S,
Sarno G,
Gutiérrez-Chico J-L,
Garcia-Garcia HM,
Gomez-Lara J,
Serruys P
April 20, 2011
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study
Brugaletta S,
Garcia-Garcia HM,
Diletti R,
Gomez-Lara J,
Garg S,
Onuma Y,
Shin E,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Chevalier B,
McClean D,
Windecker S,
Whitbourn R,
Dorange C,
Veldhof S,
Rapoza R,
Sudhir K,
Bruining N,
Ormiston J,
Serruys P
April 20, 2011
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
Sarno G,
Garg S,
Gomez-Lara J,
Garcia-Garcia HM,
Ligthart J,
Bruining N,
Onuma Y,
Witberg K,
van Geuns R,
de Boer S,
Wykrzykowska JJ,
Schultz C,
Duckers H,
Regar E,
de Jaegere P,
de Feyter P,
Van Es G-A,
Boersma E,
van der Giessen WJ,
Serruys P
March 21, 2011
1
2
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke